The histological differentiation of the human fetal prostatic urethra and the corresponding part of human fetal female urethra was studied during the 10th through 14th weeks of ovulation age.The development of all the prostatic glands started as epithelial outgrowths from the urethral wall of the urogenital sinus during the time covered in this study. These outgrowths grew rapidly in number and size, especially the posterior ones, and no outgrowths were seen from the paramesonephric and mesonephric ducts. However, the more columnar epithelial cells on the colliculus seminalis, from which the middle and posterior lobes developed, may be of different embryonic origin, e.g. mesonephric, paramesonephric and urethral, or may react differently to hormonal factors. The possible differences in the origin and in the morphological differentiation of the epithelial cells may give clues to the differences in localization of neoplastic changes in adult prostate. The gland formation was preceded by mesenchymal changes which progressed during acinic morphogenesis. Mesenchymal cells differentiated into fibroblasts forming a lamina propria the primitive acini. The mesenchymal differentiation in the corresponding part of the female urethra was not equally prominent. However, the increase in urethral epithelial cells density and cell size was more prominent in the females. These morphological differences might be regulated by sex steroids and further strengthen the current view of the role of the mesenchyme in the prostatic morphogenesis.

Keywords:
Human, Fetal, Sexual, Prostatic, Differentiation
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.